<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Can J Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Can J Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">CPA</journal-id>
<journal-id journal-id-type="hwp">spcpa</journal-id>
<journal-title-group>
<journal-title>Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie</journal-title>
</journal-title-group>
<issn pub-type="ppub">0706-7437</issn>
<issn pub-type="epub">1497-0015</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27254803</article-id>
<article-id pub-id-type="pmc">4841284</article-id>
<article-id pub-id-type="doi">10.1177/0706743716635544</article-id>
<article-id pub-id-type="publisher-id">10.1177_0706743716635544</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Apgar Scores Are Associated with Attention-Deficit/Hyperactivity Disorder Symptom Severity</article-title>
<trans-title-group xml:lang="fr">
<trans-title>Les scores d'Apgar sont associés à la gravité des symptômes du trouble de déficit de l'attention avec hyperactivité</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Grizenko</surname>
<given-names>Natalie</given-names>
</name>
<degrees>MD, FRCP(C)</degrees>
<xref ref-type="aff" rid="aff1-0706743716635544">1</xref>
<xref ref-type="aff" rid="aff2-0706743716635544">2</xref>
<xref ref-type="corresp" rid="corresp1-0706743716635544"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eberle</surname>
<given-names>Maria Loren</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff3-0706743716635544">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fortier</surname>
<given-names>Marie-Eve</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff4-0706743716635544">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Côté-Corriveau</surname>
<given-names>Gabriel</given-names>
</name>
<degrees>BMus</degrees>
<xref ref-type="aff" rid="aff5-0706743716635544">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jolicoeur</surname>
<given-names>Claude</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0706743716635544">1</xref>
<xref ref-type="aff" rid="aff2-0706743716635544">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Joober</surname>
<given-names>Ridha</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0706743716635544">1</xref>
<xref ref-type="aff" rid="aff4-0706743716635544">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0706743716635544"><label>1</label>Department of Psychiatry, McGill University, Montreal, Quebec</aff>
<aff id="aff2-0706743716635544"><label>2</label>Child and Adolescent Psychiatry Program, Douglas Mental Health University Institute, Montreal, Quebec</aff>
<aff id="aff3-0706743716635544"><label>3</label>McGill University, Montreal, Quebec</aff>
<aff id="aff4-0706743716635544"><label>4</label>Douglas Mental Health University Institute, Montreal, Quebec</aff>
<aff id="aff5-0706743716635544"><label>5</label>University of Montreal, Montreal, Quebec</aff>
<author-notes>
<corresp id="corresp1-0706743716635544">Natalie Grizenko, MD, FRCP(C), Lyall Pavilion, Douglas Mental Health University Institute, 6875 LaSalle Blvd., Verdun, Québec, H4H 1R3, Canada. Email: <email>Natalie.Grizenko@douglas.mcgill.ca</email></corresp>
<fn fn-type="conflict" id="fn1-0706743716635544">
<p><bold>Declaration of Conflicting Interests:</bold> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2016</year>
</pub-date>
<volume>61</volume>
<issue>5</issue>
<fpage>283</fpage>
<lpage>290</lpage>
<permissions>
<copyright-statement>© The Author(s) 2016</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder content-type="sage">Canadian Psychiatric Association</copyright-holder>
</permissions>
<abstract>
<sec>
<title>Objective:</title>
<p>Adverse events during pregnancy and delivery have been linked to attention-deficit/hyperactivity disorder (ADHD). Previous studies have investigated Apgar scores, which assess the physical condition of newborns, in relation to the risk of developing ADHD. We propose to go one step further and examine if Apgar scores are associated with ADHD symptom severity in children already diagnosed with ADHD.</p>
</sec>
<sec>
<title>Method:</title>
<p>ADHD symptoms severity, while off medication, was compared in 2 groups of children with ADHD: those with low (≤6, <italic>n</italic> = 52) and those with higher (≥7, <italic>n</italic> = 400) Apgar scores sequentially recruited from the ADHD clinic.</p>
</sec>
<sec>
<title>Results:</title>
<p>Children with low Apgar at 1 minute after birth had more severe symptoms as assessed by the externalizing scale of the Child Behaviour Checklist, the Conners’ Global Index for Parents, and the <italic>DSM-IV</italic> hyperactivity symptoms count (<italic>P</italic> = 0.02, &lt;0.01, &lt;0.01, respectively).</p>
</sec>
<sec>
<title>Conclusion:</title>
<p>Low 1-minute Apgar scores are associated with a significant increase in ADHD symptom severity. These findings underline the importance of appropriate pregnancy and perinatal care.</p>
</sec>
</abstract>
<trans-abstract xml:lang="fr">
<sec>
<title>Objectif:</title>
<p>Les événements indésirables durant la grossesse et l’accouchement ont été liés au trouble de déficit de l’attention avec hyperactivité (TDAH). Des études précédentes ont investigué les scores d’Apgar, qui évaluent la condition physique des nouveau-nés, en relation avec le risque de développer le TDAH. Nous proposons de faire un pas de plus et d’examiner si les scores d’Apgar sont associés à la gravité des symptômes du TDAH chez les enfants qui ont déjà reçu un diagnostic de TDAH.</p>
</sec>
<sec>
<title>Méthode:</title>
<p>La gravité des symptômes du TDAH, sans prise de médicaments, a été comparée dans deux groupes d’enfants souffrant du TDAH: ceux ayant de faibles scores d’Apgar (≤6, n = 52) et ceux chez qui ils sont élevés (≥7, n = 400), recrutés séquentiellement dans une clinique de TDAH.</p>
</sec>
<sec>
<title>Résultats:</title>
<p>Les enfants ayant de faibles scores d’Apgar une minute après la naissance avaient des symptômes plus graves tels qu’évalués par l’échelle d’externalisation de la Child Behaviour Checklist, le Conners’ Global Index for Parents et le nombre des symptômes d’hyperactivité du DSM-IV (<italic>P</italic> = 0,02; &lt; 0,01, &lt; 0,01 respectivement).</p>
</sec>
<sec>
<title>Conclusion:</title>
<p>Les faibles scores d’Apgar à une minute sont associés à un accroissement significatif de la gravité des symptômes du TDAH. Ces résultats soulignent l’importance de soins obstétriques et périnataux appropriés.</p>
</sec>
</trans-abstract>
<kwd-group>
<kwd>attention-deficit/hyperactivity disorder</kwd>
<kwd>Apgar scores</kwd>
<kwd>symptom severity</kwd>
<kwd>delivery complications</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>